Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecular Cancer Therapeutics"
DOI: 10.1158/1535-7163.mct-18-1203
Abstract: BOS172722 (CCT289346) is a highly potent, selective, and orally bioavailable inhibitor of spindle assembly checkpoint kinase MPS1. BOS172722 treatment alone induces significant sensitization to death, particularly in highly proliferative triple-negative breast cancer (TNBC) cell lines…
read more here.
Keywords:
bos172722;
spindle assembly;
assembly checkpoint;
inhibitor ... See more keywords